News

Diabetes an Independent Risk Factor for Cellulitis


 

From the Annual European Congress of Clinical Microbiology and Infectious Diseases

Major Finding: The prevalence of diabetes was 21% among patients with recurrent cellulitis compared with 6% in controls.

Data Source: A retrospective study in which 398 Finns treated for recurrent cellulitis in the year 2000 were compared with a nationally representative control group of 8,005 Finns without a history of cellulitis.

Disclosures: Dr. Karppelin said he had no conflicts of interest.

VIENNA — Diabetes is a risk factor for recurrent cellulitis independent of obesity and advanced age, according to a Finnish case-control study.

The incidence of bacterial cellulitis is reportedly increasing in many countries. The growing prevalence of type 2 diabetes coupled with the obesity epidemic and the graying of the population may be important contributors to the problem, Dr. Matti Karppelin observed at the congress.

Prior case-control studies, including one led by Dr. Karppelin (Clin. Microbiol. Infect. 2009; 16:729-34) have identified obesity but not diabetes as being linked to increased rates of acute and recurrent bacterial nonnecrotizing cellulitis. Because that study included a mere 44 patients presenting with recurrent cellulitis, Dr. Karppelin and his colleagues decided to take another look at the diabetes question in a much larger patient population.

The Finnish investigators retrospectively identified 398 Finns who were treated for recurrent cellulitis in the year 2000 and compared them with a nationally representative control group of 8,005 Finns who did not have a history of cellulitis.

The patients who had recurrent cellulitis were a median of 65 years old, 59% were women, and the group had a mean body mass index of 32.1 kg/m

Of particular interest, the prevalence of diabetes was 21% among patients with recurrent cellulitis compared with 6% in controls.

In a multivariate analysis, diabetes was associated with a 69% increased risk of recurrent cellulitis independent of advanced age or obesity, according to Dr. Karppelin of the University of Tampere, Finland.

Recommended Reading

Insulin Pump Problems Are Mostly User Related
Type 2 Diabetes ICYMI
In LEAD, Liraglutide Lowered HbA1c With No Weight Gain, Hypoglycemia
Type 2 Diabetes ICYMI
Sleep Apnea Linked With Higher HbA1c
Type 2 Diabetes ICYMI
Model Predicts Effects of Sweetened Drinks
Type 2 Diabetes ICYMI
Diabetic Patients Can Benefit From Carpal Tunnel Surgery
Type 2 Diabetes ICYMI
Novel Vector Reversed Type 1 in Early Studies : Pancreatic islet cell transplantation can result in euglycemia, but there are significant obstacles.
Type 2 Diabetes ICYMI
Diabetes Risk Follows Ethnic Lines by Age 9
Type 2 Diabetes ICYMI
Retinopathy Found in 34% of Latino Diabetes Patients
Type 2 Diabetes ICYMI
Abnormal Vascular Stiffness Prevalent in Type 1 Adolescents
Type 2 Diabetes ICYMI
Fenofibrate's Effects on Renal Function
Type 2 Diabetes ICYMI